Zivo Bioscience Inc
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically act… Read more
Market Cap & Net Worth: Zivo Bioscience Inc (ZIVO)
Zivo Bioscience Inc (NASDAQ:ZIVO) has a market capitalization of $32.12 Million ($32.12 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26489 globally and #8964 in its home market, demonstrating a -2.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zivo Bioscience Inc's stock price $8.26 by its total outstanding shares 3888595 (3.89 Million).
Zivo Bioscience Inc Market Cap History: 2015 to 2026
Zivo Bioscience Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.34 Million to $33.74 Million (31.67% CAGR).
Zivo Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zivo Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
516.68x
Zivo Bioscience Inc's market cap is 516.68 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $3.85 Million | $20.00K | -$14.67 Million | 192.49x | N/A |
| 2020 | $3.50 Million | $20.00K | -$9.66 Million | 174.99x | N/A |
| 2022 | $58.33 Million | $4.05K | -$8.75 Million | 14402.20x | N/A |
| 2023 | $4.67 Million | $27.65K | -$7.78 Million | 168.76x | N/A |
| 2024 | $81.23 Million | $157.22K | -$13.38 Million | 516.68x | N/A |
Competitor Companies of ZIVO by Market Capitalization
Companies near Zivo Bioscience Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Zivo Bioscience Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Zivo Bioscience Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Zivo Bioscience Inc's market cap moved from $1.34 Million to $ 33.74 Million, with a yearly change of 31.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $33.74 Million | -13.24% |
| 2025 | $38.89 Million | -52.13% |
| 2024 | $81.23 Million | +1640.83% |
| 2023 | $4.67 Million | -92.00% |
| 2022 | $58.33 Million | -12.89% |
| 2021 | $66.96 Million | +1813.33% |
| 2020 | $3.50 Million | -9.09% |
| 2019 | $3.85 Million | +26.92% |
| 2018 | $3.03 Million | +37.42% |
| 2017 | $2.21 Million | -0.42% |
| 2016 | $2.22 Million | +65.22% |
| 2015 | $1.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Zivo Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.12 Million USD |
| MoneyControl | $32.12 Million USD |
| MarketWatch | $32.12 Million USD |
| marketcap.company | $32.12 Million USD |
| Reuters | $32.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.